Carina Schleuniger Selected Research

glycyltryptophan

1/2020

Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [177Lu]Lu-PP-F11N.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carina Schleuniger Research Topics

Disease

1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Neoplasms (Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

1	minigastrinIBA 01/2020
1	alanyltyrosineIBA 01/2020
1	glycyltryptophanIBA 01/2020
1	aspartyl-phenylalanine (aspartylphenylalanine)IBA 01/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020
1	Everolimus FDA Link 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	LigandsIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Cholecystokinin B ReceptorIBA 01/2020

Therapy/Procedure

1	Therapeutics 01/2020